Hormel Foods (HRL) Q4 2025 earnings review
Sales Grow but Profits Collapse; Guidance Points to a Slow, Uncertain Recovery
Hormel Foods finished a challenging fiscal 2025 with consistent top-line growth, posting a 2% increase in organic net sales for Q4. However, profitability collapsed dramatically. The company reported a GAAP net loss of $56M, driven by $234M in impairment charges, and a 24% YoY decline in adjusted EPS to $0.32. Severe input cost inflation across pork and beef crushed margins in all segments. While management is guiding for a return to profit growth in FY26 (4-10% adj. operating income growth), they also forecast an earnings decline in Q1, indicating the path to recovery will be slow and heavily dependent on a second-half rebound.
🐂 Bull Case
The company achieved four consecutive quarters of organic net sales growth, demonstrating sustained consumer demand for its core brands like Jennie-O, Applegate, and Spam even in a pressured environment.
Management is taking decisive action on costs, including a corporate restructuring plan to reduce administrative expenses and continued benefits from the Transform & Modernize initiative, providing a clear lever for margin expansion in FY26.
🐻 Bear Case
Adjusted operating income fell over 20% in Q4, and the GAAP result was a net loss due to major impairments. The adjusted operating margin of 7.7% is a significant deterioration from 9.8% a year ago, showing an inability to manage costs effectively.
Guidance for a year-over-year earnings decline in Q1'26 makes the full-year recovery plan appear risky and heavily back-loaded. This lack of immediate momentum casts doubt on the achievability of the annual target.
The $234 million in non-cash impairments, including $71 million related to the snack nuts business (Planters), questions the return on recent acquisitions and suggests potential strategic missteps.
⚖️ Verdict: 🔴
Bearish. The severe and accelerating decline in profitability in Q4 overshadows the modest sales growth. The combination of widespread margin pressure across all segments, major asset impairments, and a guided earnings decline for Q1'26 signals that the company's challenges are deep-seated. The guided recovery for the full year appears optimistic and relies on a significant, yet unproven, second-half turnaround.
Key Themes
Widespread Margin Compression Accelerates
Profitability deteriorated sharply in Q4. Adjusted operating income fell 20.3% YoY, the worst performance of the year. Management cited over 500 basis points of raw material cost inflation in the quarter alone. For the full year, pork bellies increased ~25% and pork trim ~20%. This pressure was evident across all segments, with adjusted profit down 23% in Retail, 13% in Foodservice, and 7% in International, demonstrating that pricing actions have been insufficient to protect margins.
Impairment Charges Signal Trouble with Key Investments
The company recorded $234 million in non-cash impairment charges, a significant red flag concerning its capital allocation. This included a $164 million charge on a minority investment in Indonesia and a $71 million charge on intangible assets in the Retail segment, primarily related to the snack nuts business. This suggests the value of the Planters acquisition is not meeting expectations and raises questions about the International segment's strategy.
Consistent Top-Line Performance
Despite the profit challenges, Hormel has successfully driven demand, delivering four consecutive quarters of year-over-year organic net sales growth. In FY25, organic sales grew 2%, supported by gains across all three segments. This indicates the company's brand portfolio, including Jennie-O, Applegate, and Spam, retains strong consumer appeal in a difficult macroeconomic environment.
Aggressive Cost Reduction Programs
Management is actively addressing the cost structure to support margins. In addition to the ongoing Transform & Modernize (T&M) initiative, the company recently implemented a corporate restructuring plan, reducing its corporate and sales workforce by approximately 250 positions, or 9%. These actions are expected to generate meaningful savings in FY26, partially offsetting inflation and funding brand investments.
FY26 Recovery is Heavily Back-Loaded
Management explicitly guided for Q1 FY26 earnings to decline year-over-year, citing timing of pricing benefits and lingering cost pressures. This makes the full-year guidance for 4% to 10% adjusted operating income growth entirely dependent on a very strong performance in the final three quarters of the year, increasing execution risk significantly.
Strategic Shift to 'Nourishing Protein Solutions'
The company is simplifying its portfolio to focus on its core protein-centric strategy. Recent actions include the planned divestiture of the Justin's brand, exiting certain private label product lines, and selling its last non-strategic sow operation. This reflects a deliberate move to reduce commodity exposure and concentrate resources on higher-margin, branded consumer products.
Leveraging AI for Marketing and Planning
Hormel is adopting new technologies to improve efficiency. For its Skippy brand, the company used generative AI to create over 25 pieces of content in a single day. It is also implementing AI-enabled tools like O9 for integrated business planning, aiming to streamline decision-making and enhance data analytics across the organization.
Other KPIs
Declined from $1.27 billion in FY24 but remained robust relative to GAAP Net Income of $478 million, largely due to add-backs of significant non-cash impairment charges. The cash flow was sufficient to fund a record $633 million in dividends and $311 million in capital expenditures.
Increased by $171 million from the beginning of the year. Management attributes the rise to higher commodity costs inflating balances and strategic decisions to build inventory. While positioned as a proactive measure, this level represents a risk if commodity prices fall, potentially requiring write-downs.
The profitability challenge was systemic in Q4. Adjusted segment profit fell 23% in Retail, 13% in Foodservice, and 7% in International. This universal decline highlights that the margin pressure from input costs and other issues like a product recall in Foodservice was not isolated to one part of the business.
Guidance
Reversing. The midpoint of $1.47 implies a 7.3% increase from FY25's $1.37. This marks a significant reversal from the 13.3% decline experienced in FY25, signaling management's expectation that cost-cutting and pricing actions will restore bottom-line growth.
Reversing. The midpoint of $1.09 billion implies 7.0% YoY growth, a stark turnaround from the 11.1% decline in FY25. This recovery is predicated on margin expansion from T&M initiatives, restructuring savings, and pricing actions.
Stable. The midpoint of 2.5% is consistent with the 2% organic growth achieved in FY25. This suggests management expects to maintain its current top-line momentum but does not anticipate a major acceleration in demand.
Management explicitly stated they expect Q1 earnings to be below the prior year's adjusted EPS of $0.35, primarily due to the timing of pricing realization versus persistent commodity cost headwinds. This makes achieving the full-year target highly dependent on a strong recovery in Q2 through Q4.
Key Questions
On Snack Nut Impairment
The $71M impairment on snack nut intangible assets, just a few years after the Planters acquisition, is concerning. Does this change your long-term view on the profitability or strategic fit of the Planters business, and what specific actions are being taken to prevent further value destruction?
On the Back-Loaded Recovery
The FY26 guidance requires a significant acceleration in H2 after a guided decline in Q1. Can you bridge the gap by quantifying the expected quarterly contributions from pricing, restructuring savings, and the Planters recovery that give you confidence in this steep ramp-up?
On Gross Margin vs. SG&A
Gross margins were under severe pressure in FY25. Your clearest lever for FY26 profit growth appears to be SG&A reduction from restructuring. How do you plan to restore gross margin health, and is there a risk that SG&A cuts could harm the top-line momentum you've built?